NORTHERN TRUST CORP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 51 filers reported holding INOZYME PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$1,405,518
-16.0%
334,647
+11.4%
0.00%
Q2 2023$1,673,133
+536.4%
300,383
+554.7%
0.00%
Q1 2023$262,903
+445.0%
45,882
-0.1%
0.00%
Q4 2022$48,240
-55.3%
45,943
+14.0%
0.00%
Q3 2022$108,000
-51.8%
40,304
-14.2%
0.00%
Q2 2022$224,000
-51.9%
46,990
-58.7%
0.00%
Q1 2022$466,000
-43.4%
113,823
-5.7%
0.00%
Q4 2021$823,000
-38.8%
120,762
+4.0%
0.00%
Q3 2021$1,345,000
-34.6%
116,101
-3.8%
0.00%
Q2 2021$2,057,000
-10.0%
120,743
+4.6%
0.00%
Q1 2021$2,286,000
+19.4%
115,469
+24.4%
0.00%
Q4 2020$1,915,000
-21.5%
92,806
+0.0%
0.00%
-100.0%
Q3 2020$2,439,00092,7640.00%
Other shareholders
INOZYME PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$18,878,3747.53%
CHI Advisors LLC 1,270,027$5,334,1122.11%
Samsara BioCapital, LLC 1,562,500$6,562,5002.01%
Affinity Asset Advisors, LLC 1,379,852$5,795,3781.63%
Sofinnova Investments, Inc. 4,280,308$17,977,2941.13%
SPHERA FUNDS MANAGEMENT LTD. 1,234,907$5,186,6090.94%
Octagon Capital Advisors LP 1,300,000$5,460,0000.84%
NEA Management Company, LLC 2,437,689$10,238,2940.79%
Knott David M Jr 454,008$1,9070.73%
Rock Springs Capital Management LP 3,681,174$15,460,9310.41%
View complete list of INOZYME PHARMA INC shareholders